ADBIRON(Abiraterone)
Therapeutic class: CYP17 inhibitor
Indication: Combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel.
250 mg tablets
250 mg:-
A bottle of 120 tablets- 20°C to 25°C (68°F to 77°F), Shelf Life: 2 Years
- As directed by physician
